KCNN2 and Global developmental delay: It is conceivable that, while de novo KCNN2 variants found in infancy-onset development delay patients with NEDMAB could have a high disruptive effect, the variant that we identified in the ET family investigated in the present study may have a milder effect on the normal protein function and cause a milder clinical phenotype.